Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-033063
Filing Date
2025-06-25
Accepted
2025-06-25 20:29:27
Documents
1
Period of Report
2025-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750897763.html 4  
1 FORM 4 wk-form4_1750897763.xml 4 3835
  Complete submission text file 0001628280-25-033063.txt   5496
Mailing Address OPKO HEALTH, INC. 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address
Rubin Steven D (Reporting) CIK: 0001381874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37752 | Film No.: 251074841

Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
Niagen Bioscience, Inc. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)